Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial

BACKGROUND: Irritable bowel syndrome (IBS) is reported by one in ten of the population accounting for up to 40% of new referrals to gastroenterology outpatients. Patients characteristically have abdominal discomfort and disturbed bowel habit. Diarrhoea-predominant IBS is characterised by frequent lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Leighton, Matthew P, Lam, Ching, Mehta, Samir, Spiller, Robin C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551830/
https://www.ncbi.nlm.nih.gov/pubmed/23302220
http://dx.doi.org/10.1186/1745-6215-14-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551830/
https://www.ncbi.nlm.nih.gov/pubmed/23302220
http://dx.doi.org/10.1186/1745-6215-14-10

Ejemplares similares